
News|Slideshows|July 11, 2025
9 Drugs Approved for Primary Care: Q2 2025
Author(s)Sydney Jennings
Fact checked by: Grace Halsey
These new FDA-approved drugs include treatments for migraine, chronic spontaneous urticaria, RSV, and more.
Advertisement
As another quarter rounds out, a new batch of drugs have been approved by the US FDA for conditions often seen in primary care. Above, find details on the first dihydroergotamine nasal powder product to be approved for the acute treatment of migraine in adults, the first targeted therapy approved for chronic spontaneous urticaria (CSU) in more than a decade, and 7 more.
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Updated Prescribing Information for Inhaled Insulin Powder, Including New Starting Dose Guidance
2
Colorectal Cancer Becomes Leading Cause of Cancer Death in US Adults Younger Than 50 Years, Study Finds
3
Centanafadine Granted FDA Priority Review for the Treatment of ADHD Across Pediatric and Adult Populations
4

































































































































